Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis

被引：0
|
作者：
Huihui Li
Fengli Hu
Yanli Zhang
Kai Li
机构：
[1] Heze Municipal Hospital,Department of Neurology
来源：
Journal of Neurology | 2020年 / 267卷
关键词：
Disease-modifying therapy; Relapsing–remitting multiple sclerosis; Systematic review; Network meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3489 / 3498
页数：9
相关论文
共 50 条
  • [11] Safety outcomes of disease-modifying therapies for relapsing-remitting multiple sclerosis: A network meta-analysis
    Lucchetta, Rosa C.
    Leonart, Leticia P.
    Becker, Jefferson
    Pontarolo, Roberto
    Fernandez-Llimos, Fernando
    Wiens, Astrid
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 35 : 7 - 15
  • [12] A Network Meta-Analysis of Randomized Controlled Trials to Evaluate the Comparative Efficacy of Disease-Modifying Therapies for Patients with Relapsing Multiple Sclerosis
    Drudge, C.
    Walsh, S.
    Tiwari, S.
    Brennan, R.
    Boer, I.
    Haring, D. A.
    Klotz, L.
    Adlard, N.
    Banhazi, J.
    Samjoo, I. A.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 39 - 40
  • [13] COMPARING THE EFFICACY OF FIRST AND SECOND GENERATION DISEASE-MODIFYING THERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS: A NETWORK META-ANALYSIS
    Fogarty, E.
    Schmitz, S.
    Walsh, C.
    Barry, M.
    VALUE IN HEALTH, 2013, 16 (07) : A618 - A618
  • [14] The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review
    Shahtaheri, Rahil Sadat
    Nikfar, Shekoufeh
    Khorasani, Elahe
    Sabbagh-Baniazad, Mansoureh
    Goudarzi, Zahra
    Emamikhah, Maziar
    CURRENT JOURNAL OF NEUROLOGY, 2020, 19 (03): : 138 - 145
  • [15] EFFICACY AND SAFETY OF DISEASE-MODIFYING THERAPIES FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS: A SYSTEMATIC REVIEW
    Lingohr-Smith, M.
    Deitelzweig, C.
    Lin, G.
    Lin, J.
    VALUE IN HEALTH, 2021, 24 : S158 - S158
  • [16] Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing-remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis
    Lees, Samuel
    Dicker, Mathew
    Ku, Jie En
    Chaganti, Varun
    Mew-Sum, Matthew
    Wang, Nick
    Smith, Angela
    Oldmeadow, Christopher
    Goon, Wooi Lynn
    Bevan, Marc
    Lang, Danielle
    Hinwood, Madeleine
    BMJ OPEN, 2021, 11 (11):
  • [17] Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis
    Samjoo, Imtiaz A.
    Drudge, Christopher
    Walsh, Sarah
    Tiwari, Santosh
    Brennan, Roisin
    Boer, Ibolya
    Haering, Dieter A.
    Klotz, Luisa
    Adlard, Nicholas
    Banhazi, Judit
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (07)
  • [18] The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Tsivgoulis, Georgios
    Katsanos, Aristeidis H.
    Grigoriadis, Nikolaos
    Hadjigeorgiou, Georgios M.
    Heliopoulos, Ioannis
    Papathanasopoulos, Panagiotis
    Kilidireas, Constantinos
    Voumvourakis, Konstantinos
    Dardiotis, Efthimios
    PLOS ONE, 2015, 10 (12):
  • [19] Relapse reduction by disease-modifying therapies for relapsing multiple sclerosis: A network meta-analysis
    Stoneman, D.
    Drudge, C.
    Zhao, M.
    Worthington, E.
    Cameron, C.
    Haring, D.
    Samjoo, I.
    Adlard, N.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 739 - 739
  • [20] The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Tsivgoulis, Georgios
    Katsanos, Aristeidis H.
    Grigoriadis, Nikolaos
    Hadjigeorgiou, Georgios M.
    Heliopoulos, Ioannis
    Kilidireas, Constantinos
    Voumvourakis, Konstantinos
    PLOS ONE, 2015, 10 (03):
12345